NovaBay Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


NovaBay Pharmaceuticals, Inc. Website Screenshot

http://www.novabay.com

NovaBay Pharmaceuticals, Inc. Company Intro

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market.

Industry

Healthcare

NovaBay Pharmaceuticals, Inc. Headquaters

2000 Powell Street
EmeryVille,94608
United States


NovaBay Pharmaceuticals, Inc. Share price

26 Oct 2020 02:08 GMT

$0.7400

0.01 (1.37 %)


NovaBay Pharmaceuticals, Inc. Market cap

$30.257 M


WMC RANKING

2020

NovaBay Pharmaceuticals, Inc. # 156

Biotechnology



Latest NovaBay Pharmaceuticals, Inc. News

News 25 Oct 2020

(2020-2026) Viral Conjunctivitis Pipeline Drugs Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, NanoViricides

... Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, ... Inc, Shire Plc, NovaBay Pharmaceuticals, Inc, Novartis AG, Panoptes Pharma ...

News 25 Oct 2020

Impetigo Treatment Market (2020-2026) | Where Should Participant Focus To Gain Maximum ROI | Exclusive Report By DataIntelo

NovaBay Pharmaceuticals, Inc. Pfizer, Inc. Ranbaxy Laboratories Limited Roche Holding AG SANDOZ GmbH. Taro Pharmaceutical Industries Ltd Teva ...

News 25 Oct 2020

(2020-2026) Viral Conjunctivitis Pipeline Drugs Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, NanoViricides

... Development & Growth by Regions | RAdenovir Pharma AB, Allergan Plc, ... Inc, Shire Plc, NovaBay Pharmaceuticals, Inc, Novartis AG, Panoptes Pharma ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
NovaBay Pharmaceuticals, Inc. 0.12 9.33 1.68 0 0 0 8.37
Alexion Pharmaceuticals, Inc. 100 13.26 100 18 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.09 25 0 0 98.33
3SBio Inc. 96.05 0 0 4 0 0 2.80
Incyte Corporation 40.27 14.26 7.21 100 0 0 92.34

NovaBay Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
NovaBay Pharmaceuticals, Inc. $6,599 $14,261 $-10,487 $30.257M 156
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.654B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.11B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.42B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.615B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total NovaBay Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



NovaBay Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors


Book a demo

A free one-on-one demo with one of our team and see exactly what the WMC business intelligence platform can do for your organisation.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries